StockData
Pfizer Inc logo

Pfizer Inc (PFE) stock

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.47−0.39 (-1.35%)

Close on Nov 17, 2026Market cap $162.27BP/E 37.5Yield 6.04%

Pfizer shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Pfizer's shares outstanding was 5.70B at Jun 28, 2026. For fiscal 2025 it was 5.71B, up 0.2% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is 8.07B in fiscal 2010.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20255.71B+0.2%
FY2024Dec 31, 20245.70B-0.2%
FY2023Dec 31, 20235.71B-0.4%
FY2022Dec 31, 20225.73B+0.4%
FY2021Dec 31, 20215.71B+1.3%
FY2020Dec 31, 20205.63B-0.8%
FY2019Dec 31, 20195.67B-5.1%
FY2018Dec 31, 20185.98B-1.3%
FY2017Dec 31, 20176.06B-1.6%
FY2016Dec 31, 20166.16B-1.6%
FY2015Dec 31, 20156.26B-2.6%
FY2014Dec 31, 20146.42B-6.8%
FY2013Dec 31, 20136.89B-8.2%
FY2012Dec 31, 20127.51B-4.6%
FY2011Dec 31, 20117.87B-2.5%
FY2010Dec 31, 20108.07B+14.6%
FY2009Dec 31, 20097.04B+4.4%
FY2008Dec 31, 20086.75B-2.7%
FY2007Dec 31, 20076.94B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 28, 20265.70B-0.1%
Q1 FY2026Mar 29, 20265.73B+0.4%
Q4 FY2025Dec 31, 20255.72B+0.3%
Q3 FY2025Sep 28, 20255.71B+0.2%
Q2 FY2025Jun 29, 20255.71B+0.2%
Q1 FY2025Mar 30, 20255.71B+0.2%
Q4 FY2024Dec 31, 20245.70B+0.2%
Q3 FY2024Sep 29, 20245.71B+1.0%
Q2 FY2024Jun 30, 20245.70B-0.3%
Q1 FY2024Mar 31, 20245.70B-0.5%
Q4 FY2023Dec 31, 20235.69B-0.9%
Q3 FY2023Oct 1, 20235.65B-1.3%
Q2 FY2023Jul 2, 20235.71B+0.0%
Q1 FY2023Apr 2, 20235.73B-0.5%
Q4 FY2022Dec 31, 20225.75B-0.4%
Q3 FY2022Oct 2, 20225.72B-0.1%
Q2 FY2022Jul 3, 20225.71B+0.6%
Q1 FY2022Apr 3, 20225.76B+1.7%
Q4 FY2021Dec 31, 20215.77B+1.9%
Q3 FY2021Oct 3, 20215.72B+1.6%
Q2 FY2021Jul 4, 20215.68B+1.1%
Q1 FY2021Apr 4, 20215.66B+0.9%
Q4 FY2020Dec 31, 20205.66B+0.6%
Q3 FY2020Sep 27, 20205.63B-0.3%
Q2 FY2020Jun 28, 20205.62B-0.9%
Q1 FY2020Mar 29, 20205.61B-2.4%
Q4 FY2019Dec 31, 20195.63B-4.8%
Q3 FY2019Sep 29, 20195.65B-5.6%
Q2 FY2019Jun 30, 20195.67B-4.7%
Q1 FY2019Mar 31, 20195.75B-5.1%
Q4 FY2018Dec 31, 20185.91B-2.4%
Q3 FY2018Sep 30, 20185.99B-0.9%
Q2 FY2018Jul 1, 20185.95B-1.4%
Q1 FY2018Apr 1, 20186.06B-0.6%
Q4 FY2017Dec 31, 20176.06B-0.8%
Q3 FY2017Oct 1, 20176.04B-1.8%
Q2 FY2017Jul 2, 20176.04B–
Q1 FY2017Apr 2, 20176.09B–
Q4 FY2016Dec 31, 20166.11B–
Q3 FY2016Oct 2, 20166.15B–

More Pfizer figures

See a number that looks wrong?